Expand LXRX Menu
LXRX MENU

LXRX Latest Press Releases

-- June 3, 2026 --

Lexicon to Present Data at the American Diabetes Association (ADA) 2026 Scientific Sessions Globe Newswire 8:00 AM

-- May 28, 2026 --

Lexicon Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference Globe Newswire 8:30 AM

-- May 12, 2026 --

Lexicon Pharmaceuticals to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference Globe Newswire 8:30 AM

-- May 7, 2026 --

Lexicon Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Clinical Updates Globe Newswire 7:30 AM

-- May 4, 2026 --

Lexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital Globe Newswire 4:05 PM

-- April 30, 2026 --

Lexicon Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026 Globe Newswire 8:00 AM

-- April 17, 2026 --

Lexicon to Present Data at the American Academy of Neurology (AAN) Annual Meeting Globe Newswire 8:00 AM

-- March 24, 2026 --

Lexicon Announces Three Presentations at the American College of Cardiology (ACC) Annual Scientific Session & Expo Globe Newswire 8:00 AM

-- March 23, 2026 --

Lexicon Pharmaceuticals and Novo Nordisk Announce initiation of Phase 1 study with oral obesity drug candidate LX9851 Globe Newswire 7:30 AM

-- March 11, 2026 --

Lexicon to Present Data on Effect of Kidney Function on the Long-term Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes at 19th International Conference on Advanced Technologies & Treatments for Diabetes Globe Newswire 8:00 AM

-- March 5, 2026 --

Lexicon Pharmaceuticals Reports Fourth Quarter 2025 Financial Results and Provides Clinical Updates Globe Newswire 6:59 AM

-- March 3, 2026 --

Chronic Kidney Disease Market Poised to Expand Significantly During Forecast Period (2025-2034) as Demand for Early Diagnosis and Novel Therapies Increases | DelveInsight PRNewswire 5:31 PM
Lexicon Pharmaceuticals to Participate in Three Upcoming March Investor Conferences Globe Newswire 4:01 PM

-- February 26, 2026 --

Lexicon Pharmaceuticals to Report Fourth Quarter 2025 Financial Results on March 5, 2026 Globe Newswire 8:30 AM

-- February 6, 2026 --

Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement Globe Newswire 5:17 PM

-- January 30, 2026 --

Lexicon Announces Pricing of Approximately $94.6 Million Public Offering and Concurrent Private Placement Globe Newswire 2:50 AM

-- January 29, 2026 --

Lexicon Announces Proposed Public Offering of Common Stock Globe Newswire 4:31 PM

-- January 23, 2026 --

Lexicon Pharmaceuticals to Ring the Nasdaq Closing Bell on January 27, 2026 to Celebrate 30th Anniversary Globe Newswire 8:30 AM

-- January 21, 2026 --

Lexicon Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA For Pilavapadin in the Treatment of Diabetic Peripheral Neuropathic Pain Globe Newswire 8:30 AM

-- January 20, 2026 --

Viatris Expands Innovative Portfolio in Cardiovascular Diseases with the Company's First Launch of Inpefa (Sotagliflozin) for the Treatment of Heart Failure PRNewswire 6:59 AM

-- January 12, 2026 --

Lexicon Pharmaceuticals Provides a Business and Pipeline Update at the 44th Annual J.P. Morgan Healthcare Conference Globe Newswire 7:30 AM

-- January 9, 2026 --

Lexicon Pharmaceuticals Publishes "Relief is Possible: Ensuring Access to Effective Treatments for Chronic Pain" Globe Newswire 8:30 AM

-- January 7, 2026 --

Lexicon Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference Globe Newswire 8:30 AM
Market Data Delayed 15 Minutes